Jul 10, 2026Aging BiomarkersBlood Biomarkers May Improve Cognitive-Decline Trial EnrollmentGFAP, NfL, p-tau, and amyloid blood tests may help enroll higher-risk cognitive-decline trial participants, but they cannot yet predict your future.gfapnflphosphorylated tauamyloid ratiosRead article →
Mar 18, 2026NutritionKeto in MS Lowers Leptin, but Nerve-Injury Marker Stays FlatA ketogenic diet changes leptin and adiponectin in multiple sclerosis, but current studies show no reduction in neurofilament light chain.ketogenic dietleptinmultiple sclerosisadiponectinRead article →